These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30981626)

  • 21. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
    Baqar S; Bonavia A; Louis Bourgeois A; Campo JJ; Clifford A; Hanevik K; Hasso-Agopsowicz M; Hausdorff W; Kaminski R; MacLennan CA; Mantis N; Martin LB; Omore R; Pasetti M; Pavlinac P; Phalipon A; Poly F; Porter C; Ramasamy MN; Rogawski McQuade ET; Sztein MB; Walker R
    Vaccine; 2024 Mar; 42(7):1445-1453. PubMed ID: 38036392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A roadmap for enterotoxigenic
    Levine MM; Barry EM; Chen WH
    Hum Vaccin Immunother; 2019; 15(6):1357-1378. PubMed ID: 30724648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.
    Jelinek T; Kollaritsch H
    Expert Rev Vaccines; 2008 Jul; 7(5):561-7. PubMed ID: 18564011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques.
    Kotloff KL; Platts-Mills JA; Nasrin D; Roose A; Blackwelder WC; Levine MM
    Vaccine; 2017 Dec; 35(49 Pt A):6783-6789. PubMed ID: 28765005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
    Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
    Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
    Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening.
    Riddle MS; Louis Bourgeois A; Clifford A; Jeon S; Giersing BK; Jit M; Tufet Bayona M; Ovitt J; Hausdorff WP
    Vaccine; 2023 Apr; 41(16):2634-2644. PubMed ID: 36932030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining cases of severe pediatric diarrhea for an efficacy trial of an enterotoxigenic Escherichia coli (ETEC) vaccine: Report on an international workshop, Washington DC, March 2016.
    Wierzba TF; Bourgis A;
    Vaccine; 2017 Jan; 35(4):503-507. PubMed ID: 28034476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints.
    MacLennan CA; Riddle MS; Chen WH; Talaat KR; Jain V; Bourgeois AL; Frenck R; Kotloff K; Porter CK
    Clin Infect Dis; 2019 Dec; 69(Suppl 8):S591-S595. PubMed ID: 31816065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines against enterotoxigenic Escherichia coli.
    Svennerholm AM; Tobias J
    Expert Rev Vaccines; 2008 Aug; 7(6):795-804. PubMed ID: 18665777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel antigens for enterotoxigenic Escherichia coli vaccines.
    Fleckenstein J; Sheikh A; Qadri F
    Expert Rev Vaccines; 2014 May; 13(5):631-9. PubMed ID: 24702311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
    Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines to prevent travelers' diarrhea.
    Levine MM
    Ther Umsch; 1983 Mar; 40(3):253-6. PubMed ID: 6344308
    [No Abstract]   [Full Text] [Related]  

  • 36. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
    Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy.
    Hosangadi D; Smith PG; Giersing BK
    Vaccine; 2019 Nov; 37(50):7372-7380. PubMed ID: 29031690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
    Tobias J; Svennerholm AM
    Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
    McKenzie R; Darsley M; Thomas N; Randall R; Carpenter C; Forbes E; Finucane M; Sack RB; Hall E; Bourgeois AL
    Vaccine; 2008 Aug; 26(36):4731-9. PubMed ID: 18602960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus.
    Das JK; Tripathi A; Ali A; Hassan A; Dojosoeandy C; Bhutta ZA
    BMC Public Health; 2013; 13 Suppl 3(Suppl 3):S11. PubMed ID: 24564510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.